An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...
The Tesla Model Y is already one of the most popular EVs on the planet, and an extensive update gives it renewed interest. The so-called “Juniper” refresh for the Model Y arrived in 2025 and mirrors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results